Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease – DocWire News

Posted: Published on May 19th, 2022

This post was added by Alex Diaz-Granados

This article was originally published here

Folia Microbiol (Praha). 2022 May 18. doi: 10.1007/s12223-022-00977-2. Online ahead of print.

ABSTRACT

Advanced research in health science has broadened our view in approaching and understanding the pathophysiology of diseases and has also revolutionised diagnosis and treatment. Ever since the establishment of Braaks hypothesis in the propagation of alpha-synuclein from the distant olfactory and enteric nervous system towards the brain in Parkinsons Disease (PD), studies have explored and revealed the involvement of altered gut microbiota in PD. This review recapitulates the gut microbiome associated with PD severity, duration, motor and non-motor symptoms, and antiparkinsonian treatment from recent literature. Gut microbial signatures in PD are potential predictors of the disease and are speculated to be used in early diagnosis and treatment. In brief, the review also emphasises on implications of the prebiotic, probiotic, faecal microbiota transplantation, and dietary interventions as alternative treatments in modulating the disease symptoms in PD.

PMID:35583791 | DOI:10.1007/s12223-022-00977-2

Read the original post:
Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease - DocWire News

Related Posts
This entry was posted in Parkinson's Treatment. Bookmark the permalink.

Comments are closed.